Page 4 - Polypid Ltd News Today

Operator: Greetings, and welcome to the PolyPid Second Quarter 2023 Conference Call. [Operator Instructions].

Reached Agreement with U.S. FDA on Design of SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Resumed Recruitment into SHIELD II Phase 3 Trial in Late June 2023 Total of 20 centers in U.S., Europe and Israel Expected to be Opened by End of Current Quarter Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Compan...

PolyPid (NASDAQ:PYPD – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Parties that wish to listen to the company’s conference call can do so using this link. PolyPid (NASDAQ:PYPD – Get Free Report) last posted its quarterly earnings results on Wednesday, May 10th. The […]

Acutus Medical (NASDAQ:AFIB – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Analyst Recommendations This is a summary of recent […]

PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover […]

PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover ratio is currently […]

PolyPid (NASDAQ:PYPD – Get Rating) and Ra Medical Systems (NYSE:RMED – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 2.5% of PolyPid shares are […]

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) shares traded up 4.8% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.37. 94,833 shares were traded during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Price Performance […]

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was up 4.8% during trading on Wednesday . The company traded as high as $0.39 and last traded at $0.37. Approximately 94,833 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Stock […]

Operator: Greetings, and welcome to the PolyPid First Quarter 2023 Conference Call. At this time participants are in a listen-only mode. As a reminder this call is recorded.